Edward Garmey MD, Alacrita Consultant, is lecturing at Harvard Medical School on June 23.
Edward's lecture, titled "Checkpoint inhibitors in the treatment of cancer" will present CPIs as a model for harnessing and enabling the body's immune system in the war against cancer.
The lecture is part of a course to introduce translational medicine to MD and PhD students and will specifically focus on the investigation of how unmet medical needs are identified and addressed.